Back to Alerts
General•10d ago

PHR Maintained by Freedom Capital Markets -- Price Target Remains at $14

PHR Maintained by Freedom Capital Markets -- Price Target Remains at $14

On October 3, 2023, Phreesia (PHR) received a 'Buy' rating from Freedom Capital Markets, with analyst Gene Mannheimer maintaining the price target at $14.00. Th

GuruFocus
Article
News
GuruFocus News
PHR
Source: gurufocus.com

Sponsored

Sponsored

Master the Millennial Market mindset

Learn advanced portfolio strategies for 2024

Market Sectors

Blogs12

Markets8

Subscribers15

Related Alerts

3 Reports
PHR Reiterated by RBC Capital -- Price Target Maintained at $19.00Healthcare
Source: gurufocus.com10d ago

PHR Reiterated by RBC Capital -- Price Target Maintained at $19.00

On October 03, 2023, RBC Capital maintained an "Outperform" rating for Phreesia (PHR), with the current price target remaining steady at $19.00. This reiteratio

Verified Marketplace IntelligenceREAD REPORT
PHR Reiterated by Needham -- Price Target Maintained at $14.00Healthcare
Source: gurufocus.com10d ago

PHR Reiterated by Needham -- Price Target Maintained at $14.00

Phreesia (PHR) Analyst Rating Update On September 3, 2026, Needham analyst Ryan MacDonald reaffirmed the Buy rating on Phreesia (PHR), maintaining the price

Verified Marketplace IntelligenceREAD REPORT
PHR Maintained by Canaccord Genuity -- Price Target Stays at $16Healthcare
Source: gurufocus.com10d ago

PHR Maintained by Canaccord Genuity -- Price Target Stays at $16

On October 3, 2023, Phreesia (PHR) had its rating maintained at "Buy" by Canaccord Genuity. Analyst Richard Close confirmed the "Buy" rating while keeping the a

Verified Marketplace IntelligenceREAD REPORT